PPARs and LXRs: atherosclerosis goes nuclear
- 31 May 2004
- journal article
- review article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 15 (4) , 158-165
- https://doi.org/10.1016/j.tem.2004.03.003
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Expression of the Insulin-responsive Glucose Transporter GLUT4 in Adipocytes Is Dependent on Liver X Receptor αJournal of Biological Chemistry, 2003
- Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat MassJournal of Biological Chemistry, 2003
- The peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein EBiochemical Journal, 2003
- Critical roles of PPARβ/δ in keratinocyte response to inflammationGenes & Development, 2001
- A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and AtherogenesisMolecular Cell, 2001
- Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβGenes & Development, 2000
- Activation of PPARδ alters lipid metabolism in db/db miceFEBS Letters, 2000
- Peroxisome proliferator–activated receptor α mediates the adaptive response to fastingJournal of Clinical Investigation, 1999
- Activation of Proliferator-activated Receptors α and γ Induces Apoptosis of Human Monocyte-derived MacrophagesJournal of Biological Chemistry, 1998
- An oxysterol signalling pathway mediated by the nuclear receptor LXRαNature, 1996